Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
our similar early study and recent confirming experiments using the same reagents reported by Sheng et al. failed to reproduce the phenotype of the loss of dopaminergic neurons, although the mRNA of LRRK2 was molecularly disrupted
results demonstrate that zLRRK2 is an ortholog of hLRRK2 and that the deletion of WD40 domain (show DCAF12L2 Proteins) of zLRRK2 provides a disease model for PD
Study created a conditional LRRK2 G2019S (LRRK2 GS) mutant and a functionally negative control, LRRK2 G2019S/D1994A (LRRK2 GS/DA). Overexpression of LRRK2 GS in mouse forebrain induced behavioral deficits and alpha-synuclein pathology in a kinase-dependent manner.
This study showed that Parkinson disease patients as well as those with LRRK2 mutations present with increased levels of the pro-inflammatory serum markers indicating a common disease status-specific pattern.
The results of this study strengthen the link between LRRK2 and the innate immunity system underscoring the involvement of inflammatory pathways in the neurodegenerative process in Parkinson disease.
we conclude that LRRK2 G2019S mutation most likely originated in a Berber founder who lived at least 5000 years ago.
We discovered a new missense mutation in the LRRK2 gene, c.4321C>A (p.R1441S). LRRK2 p.R1441S represents the fourth pathogenic mutation observed within codon 1441 and its discovery adds to the remarkable complexity of a mutational hotspot within the ROC domain of the LRRK2 protein
The Parkinson's disease-associated LRRK2 mutant G2019S impairs DRD1 (show DRD1 Proteins) internalization, leading to an alteration in signal transduction. The mutant forms of LRRK2 also affect receptor turnover by decreasing the rate of DRD2 (show DRD2 Proteins) trafficking from the Golgi complex to the cell membrane.
we have identified a novel genetic association between the autophagy-related LRRK2 gene and susceptibility to SLE.
There was no significant difference between nonmanifesting family members with and without a LRRK2 mutation in any of the 5 HRV parameters investigated.
These results indicate that LRRK2 and alpha-synuclein participate in the dysregulation of CADPS2 (show CADPS2 Proteins) by altering transcription and support the hypothesis that synaptic dysfunctions, through different mechanisms, might contribute to the neuronal defects of diseases such as Parkinson's disease.
each mutation in LRRK2 and ARHGEF7 (show ARHGEF7 Proteins) demonstrated its unique functional property, which may contribute to the pathogenesis of Parkinson disease
promotes activation of NLRC4 (show NLRC4 Proteins) inflammasome during Salmonella Typhimurium infection
LRRK2 negatively regulates the clearance of alphaSYN accompanied by down-regulation of the endocytosis pathway; LRRK2 in microglia may function as the offending molecule responsible for neurodegeneration, in terms of down-regulation of alphaSYN clearance.
In addition to disease modeling, leucine-rich repeat kinase 2 (LRRK2) konckin (KI) mice represent a valuable resource for pharmacological studies.
These results of this study demonstrate that alpha-synuclein inclusion formation in neurons can be blocked and that novel therapeutic compounds targeting this process by inhibiting LRRK2 kinase activity may slow progression of PD-associated pathology.
The findings of this study indicated that the G2019S mutation of LRRK2 imparts a gain-of-abnormal function to striatal spiny projection neurons activity and morphology during a stage of development when activity can permanently modify circuit structure and function.
LRRK2 is expressed in enteric neurons and related to alterations of neuronal peptides and IgA.
our findings reveal a previously unknown regulatory role for LRRK2 in CX3CR1 (show CX3CR1 Proteins) signalling and suggest that an increase of CX3CR1 (show CX3CR1 Proteins) activity contributes to the attenuated inflammatory responses in Lrrk2-null microglia
this study reveals that LRRK2 is a new positive regulator of Rip2 and promotes inflammatory cytokine induction through the Nod1/2-Rip2 pathway.
LRRK2 kinase activity in microglia can contribute to neuroinflammation in Parkinson's disease via phosphorylating p53 (show TP53 Proteins) at T304 and T377 site
show that the LRRK2 sequence and expression patterns are conserved between pig and human
This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8.
leucine-rich repeat serine/threonine-protein kinase 2
, leucine-rich repeat kinase 2
, leucine-rich repeat serine/threonine-protein kinase 2-like
, augmented in rheumatoid arthritis 17